Screening for depression, anxiety, and suicide risk in children and adolescents an evidence review for the U.S. Preventive Services Task Force
The review was limited to drugs approved for pediatric use by the Food and Drug Administration (FDA). For anxiety, psychotherapy was limited to CBT. CONCLUSIONS: We found no eligible studies that reported on benefits directly arising from screening when compared with usual care or no screening. Limi...
| Main Author: | |
|---|---|
| Corporate Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
Rockville, MD
Agency for Healthcare Research and Quality
October 2022, 2022
|
| Series: | Evidence synthesis
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references